Opinion

Video

Healthcare Specialties Involved in Managing Patients With Chronic Spontaneous Urticaria 

Author(s):

Brian Keegan, MD, PhD,Giselle Mosnaim, MD

A panel of experts discuss the healthcare specialties that become involved in treating patients with CSU.

Video content above is prompted by the following question(s):

  • Which healthcare specialties are involved in managing patients with CSU, and how can multidisciplinary care be optimized?
  • What are the comorbidities that are most seen in patients with CSU, and how do these affect your management plan?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Gordon Crofoot, MD, PA
Dr Brian Slomovitz
4 experts are featured in this series.
2 experts in this video
2 experts in this video
4 experts are featured in this series.
1 expert in this video
5 experts are featured in this series
Related Content
The findings support the use of luspatercept as the first-line standard of care for anemia treatment in patients with MDS. | Image Credit: wanchalerm - stock.adobe.com
June 5th 2025

Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS

Rose McNulty
Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
managed care cast logo
December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick
On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
Gary Falcetano, PA-C, AE-C.
June 4th 2025

Proactively Protecting Mental and Physical Health During Peak Allergy Season With Gary Falcetano, PA-C, AE-C

Cameron Santoro Gary Falcetano, PA-C, AE-C
Gary Falcetano, PA-C, AE-C, explains that proactively managing seasonal allergies can significantly decrease the overall inflammatory burden, thereby improving both physical symptoms and potentially mitigating neuroinflammation's impact on mental well-being.
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.
Gary Falcetano, PA-C, AE-C.
June 3rd 2025

Understanding the Mental Health Burden of Chronic Allergies and Early Diagnosis: Insights From Thermo Fisher's Gary Falcetano

Cameron Santoro Gary Falcetano, PA-C, AE-C
Gary Falcetano, PA-C, AE-C, features insights on how unaddressed chronic allergy symptoms contribute to mental health burdens and the critical role of early immunoglobulin E trigger identification in managing both physical and psychological wellbeing.
Peanut allergy. | Image Credit: Angela Schmidt - stock.adobe.com
June 3rd 2025

Peanut Oral Immunotherapy Extends Relief to Adults, Highlights Need for Future Research

Cameron Santoro
Adults with peanut allergy experienced effective treatment with peanut oral immunotherapy but future studies are necessary to confirm and characterize safety profiles among various subgroups.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo